ACADIA Pharmaceuticals Inc. · LS:603035

ACADIA Pharmaceuticals Inc. insider trades

ACADIA Pharmaceuticals Inc.'s insiders made 0 buys and 12 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Schneyer Mark C.
Officer: EVP, CHIEF FINANCIAL OFFICER
Sale3,321USD 20.88US$69,342Oct 30, 2026
Schneyer Mark C.
Officer: EVP, CHIEF FINANCIAL OFFICER
Sale5,000USD 29.00US$145KAug 6, 2026
Schneyer Mark C.
Officer: EVP, CHIEF FINANCIAL OFFICER
Sale9,292USD 29.34US$273KAug 6, 2026
Schneyer Mark C.
Officer: EVP, CHIEF FINANCIAL OFFICER
Sale5,849USD 29.00US$170KAug 5, 2026
Thompson Elizabeth H.Z.
Officer: EVP, Head of Research & Dev
Sale16,508USD 26.13US$431KJul 30, 2026
Thompson Elizabeth H.Z.
Officer: EVP, Head of Research & Dev
Sale50USD 26.17US$1,309Jul 30, 2026
Kihara James
Officer: PRINCIPAL ACCOUNTING OFFICER
Sale11,421USD 26.08US$298KJun 26, 2026
Kihara James
Officer: PRINCIPAL ACCOUNTING OFFICER
Sale5,401USD 21.18US$114KMay 26, 2026
Kihara James
Officer: PRINCIPAL ACCOUNTING OFFICER
Sale1,332USD 21.79US$29,024May 4, 2026
Schneyer Mark C.
Officer: EVP, CHIEF FINANCIAL OFFICER
Sale3,506USD 21.79US$76,396May 4, 2026
Kihara James
Officer: PRINCIPAL ACCOUNTING OFFICER
Sale1,030USD 22.20US$22,866Apr 7, 2026
Schneyer Mark C.
Officer: EVP, CHIEF FINANCIAL OFFICER
Sale2,709USD 22.20US$60,140Apr 7, 2026

ACADIA Pharmaceuticals Inc. shareholders